Located on Chromosome 16, this mutation impacts MVP-DT, PRRT2 (MVP divergent transcript| proline rich transmembrane protein 2). What is its biological consequence — is it benign or pathogenic, and which disease is associated if any?
Pathogenic; Episodic kinesigenic dyskinesia